Trinity Biotech Plc (TRIB)
5.69
-0.63
(-9.97%)
USD |
NASDAQ |
Oct 02, 16:00
5.46
-0.23
(-4.04%)
After-Hours: 20:00
Trinity Biotech Profit Margin (Quarterly) : -40.74% for March 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -40.74% |
| December 31, 2025 | -157.8% |
| September 30, 2025 | -35.88% |
| June 30, 2025 | -55.09% |
| March 31, 2025 | -116.2% |
| December 31, 2024 | -103.3% |
| September 30, 2024 | -31.41% |
| June 30, 2024 | -42.65% |
| March 31, 2024 | -22.56% |
| December 31, 2023 | -40.97% |
| September 30, 2023 | -45.79% |
| June 30, 2023 | -132.0% |
| March 31, 2023 | -42.52% |
| December 31, 2022 | -66.21% |
| September 30, 2022 | -63.60% |
| June 30, 2022 | -65.63% |
| March 31, 2022 | -10.67% |
| December 31, 2021 | 7.78% |
| September 30, 2021 | 6.14% |
| June 30, 2021 | 20.45% |
| March 31, 2021 | 6.26% |
| December 31, 2020 | 23.66% |
| September 30, 2020 | 22.88% |
| June 30, 2020 | -9.16% |
| March 31, 2020 | 0.96% |
| Date | Value |
|---|---|
| December 31, 2019 | 5.26% |
| September 30, 2019 | 0.10% |
| June 30, 2019 | -24.03% |
| March 31, 2019 | -0.96% |
| December 31, 2018 | 4.99% |
| September 30, 2018 | 3.78% |
| June 30, 2018 | 2.38% |
| March 31, 2018 | 1.59% |
| December 31, 2017 | 5.60% |
| September 30, 2017 | 1.74% |
| June 30, 2017 | 3.54% |
| March 31, 2017 | 5.29% |
| December 31, 2016 | 20.75% |
| September 30, 2016 | -1.98% |
| June 30, 2016 | 8.00% |
| March 31, 2016 | -5.73% |
| December 31, 2015 | 11.33% |
| September 30, 2015 | 47.60% |
| June 30, 2015 | 11.11% |
| March 31, 2015 | 15.88% |
| December 31, 2014 | 15.46% |
| September 30, 2014 | 16.06% |
| June 30, 2014 | 16.59% |
| March 31, 2014 | 17.63% |
| December 31, 2013 | 18.22% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | -417.3% |
| Akari Therapeutics Plc | -- |
| Autolus Therapeutics Plc | -85.60% |
| Evaxion AS | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.37% |
| Return on Invested Capital | -51.65% |
| Operating Margin (Quarterly) | -26.60% |
| Return on Net Operating Assets | -35.90% |